| Financial Year |
March 31 2023 |
| Monetary Funds |
2,601,410,044.52 |
| Held-for-trading Financial Assets |
183,474.72 |
| Notes Receivable |
7,074,626.00 |
| Accounts Receivable |
1,276,967,971.97 |
| Advances to Suppliers |
1,068,308,412.34 |
| Other Receivables |
10,287,418,423.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,023,794.64 |
| Inventories |
40,217,608,688.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,209,077.09 |
| Other Current Assets |
2,104,797,403.52 |
| Total Current Assets |
57,870,878,754.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,950,216,484.99 |
| Investment Properties |
4,562,951,790.80 |
| Fixed Assetes |
307,395,750.15 |
| Under-construction Projects |
115,908,693.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,784,062.75 |
| R&D expenses |
15,477,756.23 |
| Goodwill |
214,144,109.90 |
| Long-Term Deferred and Prepaid Expenses |
99,602,952.45 |
| Deferred Income Tax Assets |
1,425,725,482.23 |
| Other Non-Current Assets |
53,134,307.45 |
| Sub-Total of Non-Current Assets |
10,976,130,406.89 |
| Total Assets |
68,847,009,161.82 |
| Short-Term Loans |
1,741,591,070.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
744,270,689.33 |
| Accounts Payable |
9,575,001,100.07 |
| Accounts Received In Advance |
13,825,056.67 |
| Employee Compensation Payable |
268,817,627.08 |
| Taxes Payable |
1,333,327,239.76 |
| Interest Payable |
504,007,295.66 |
| Dividend Payable |
5,386,290.60 |
| Other payables |
8,897,871,245.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,020,055,449.77 |
| Other Current Liabilities |
3,954,619,675.08 |
| Sub-Total of Current Liabilities |
50,218,267,115.59 |
| Long-term Loans |
3,952,611,101.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,117,964,285.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
506,729,035.54 |
| Deferred Income Tax Liabilities |
315,121,814.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,065,742,314.08 |
| Total Liabilities |
56,284,009,429.67 |
| Paid-In Capital(Or Share Stock) |
2,491,506,284.00 |
| Capital Surplus |
2,287,847,637.76 |
| Surplus Reserve |
389,613,793.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-684,673,729.84 |
| Minority Stockholder's Interest |
7,594,976,904.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,968,022,827.87 |
| Owner's Equity（Stockholder's Equity） |
12,562,999,732.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
68,847,009,161.82 |
